Evommune Inc (EVMN)

$18.41 -1.82 (-9.00%)
Market Cap N/A
Revenue (ttm) 7.00M
Net Income (ttm) -66.81M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin -975.83%
Debt to Equity Ratio N/A
Volume 347,000
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A
Latest News on EVMN
Evommune Announces Pricing of its Initial Public Offering

Nov 5, 2025, 7:45 PM EST - 8 days ago

Evommune Announces Pricing of its Initial Public Offering

Evommune Announces Commencement of Initial Public Offering

Oct 30, 2025, 6:30 AM EDT - 15 days ago

Evommune Announces Commencement of Initial Public Offering

Evommune Aims For IPO In Bifurcated Biopharma Market

Oct 14, 2025, 4:01 PM EDT - 4 weeks ago

Evommune Aims For IPO In Bifurcated Biopharma Market

Evommune files for IPO to advance immune drug work

Oct 10, 2025, 8:31 AM EDT - 5 weeks ago

Evommune files for IPO to advance immune drug work

Evommune IPO Registration Document (S-1)

Oct 9, 2025, 2:18 PM EDT - 5 weeks ago

Evommune IPO Registration Document (S-1)

Chronic inflammatory disease biotech Evommune files for a $100 million IPO

Oct 9, 2025, 10:32 AM EDT - 5 weeks ago

Chronic inflammatory disease biotech Evommune files for a $100 million IPO